# Noble Life Sciences, Inc. — Form D

Noble Life Sciences, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2012-04-10. The offering totals $235K, of which $235K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2012-04-10
- Form: D
- Accession: 0001546887-12-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $235K
- Amount sold: $235K
- Investors: 5
- Date of first sale: 2010-12-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-176430

## Issuer

- Name: Noble Life Sciences, Inc.
- CIK: 0001546887
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 22 FIRSTFIELD ROAD, GAITHERSBURG, MD, 20878
- Phone: 301-861-0009

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Kenneth Carter | Director | SAN FRANCISCO, CA |
| Alain Cappeluti | Executive Officer | Gaithersburg, MD |
| Kenneth Carter | Executive Officer | SAN FRANCISCO, CA |

## More

- [CIK 1546887 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1546887&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001546887-12-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.